AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2008

Apr 4, 2008

29831_dirs_2008-04-03_10a5fbcc-0a3c-4672-baeb-284113d76a0a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ENCYSIVE PHARMACEUTICALS INC (ENCY)
CIK: 0000887023
Period of Report: 2008-04-01

Reporting Person: PFIZER INC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70238869	Indirect

Footnotes

F1: Represents 70,238,869 shares purchased by tender offer by Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer
Inc., including 8,473,574 shares that are subject to guaranteed delivery procedures.

F2: Shares owned directly by Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer Inc.